Papers

3

Total Citations

25

H-Index

3

About

Jean Faivre is a radiation oncologist whose research focuses on advancing stereotactic radiation therapy techniques for treating brain and lung tumors. Her work critically evaluates the comparative effectiveness of modern radiosurgery platforms, particularly in her highly cited 2023 study comparing the HyperArc™ and CyberKnife® techniques for stereotactic treatment of brain metastases (13 citations). Faivre has also made significant contributions to optimizing lung cancer treatment, investigating whether fiducial marker implantation remains necessary for CyberKnife® stereotactic body radiation therapy (SBRT) in stage I lung cancer and pulmonary oligometastases (6 citations). Her research provides valuable clinical guidance on streamlining treatment workflows while maintaining efficacy. Earlier in her career, Faivre addressed the challenging clinical scenario of cervical lymph node metastases from unknown primary cancers, documenting diagnostic advances and implications of the updated TNM classification system (6 citations). Through her comparative technology studies and practical treatment optimization research, Faivre has helped refine stereotactic radiation protocols, directly impacting clinical decision-making for patients with metastatic disease. Her work demonstrates a commitment to evidence-based refinement of advanced radiation oncology techniques.

Research Focus

Key Achievements

3
H-Index
3
Papers
25
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases
13 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Institut de Cancérologie de Lorraine, Centre Georges François Leclerc

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago